Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23
ConclusionThe novel FGF23 assay tested in this study is useful for the differential diagnosis of hypophosphatemic rickets/osteomalacia in a clinical setting.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemistry | Japan Health | Orthopaedics | Study | Vitamin D | Vitamin D Deficiency | Vitamins